LYMPHOPROLIFERATIVE DISEASE
Clinical trials for LYMPHOPROLIFERATIVE DISEASE explained in plain language.
Never miss a new study
Get alerted when new LYMPHOPROLIFERATIVE DISEASE trials appear
Sign up with your email to follow new studies for LYMPHOPROLIFERATIVE DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Supercharged immune cells take on Virus-Linked cancers
Disease control Recruiting nowThis study tests a new way to make special immune cells (T cells) that can attack cancer cells infected with the Epstein-Barr virus (EBV). The cells are grown faster in the lab and given to patients with Hodgkin or non-Hodgkin lymphoma, or related diseases that have come back or …
Matched conditions: LYMPHOPROLIFERATIVE DISEASE
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 17, 2026 00:49 UTC
-
Massive 10-Year registry aims to unlock secrets of blood cancers
Knowledge-focused Recruiting nowThis study is a large registry that will follow 9,000 adults with lymphoproliferative disorders (a type of blood cancer) for up to 10 years. Researchers will track survival, how well different treatments work, and factors like genetics and overall health that affect outcomes. The…
Matched conditions: LYMPHOPROLIFERATIVE DISEASE
Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia • Aim: Knowledge-focused
Last updated May 11, 2026 20:48 UTC